It’s been more than two years since Eli Lilly announced LillyDirect, a platform that combines telehealth and pharmacy services to provide access to Lilly’s portfolio of diabetes, migraine and obesity medications. The goal is to offer a more transparent and affordable way to access certain drugs. The platform has quickly drawn attention from both consumers and lawmakers.
To understand LillyDirect’s growth and where it’s headed, Senior Writer Anastassia Gliadkovskaya spoke with Jen Mazur, senior vice president and general manager of U.S. LillyDirect and Consumer Services.
To learn more about the topics in this episode:

ACCESS Model: behavioral health edition
34:35

Badges, bots and blind spots
24:50

Why one life insurer is going big on health incentives
30:50